MetLife Investment Management’s Cadre Holdings CDRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$492K Buy
16,022
+216
+1% +$8.63K ﹤0.01% 1758
2025
Q4
$646K Sell
15,806
-1,115
-7% -$46.4K ﹤0.01% 1673
2025
Q3
$618K Hold
16,921
﹤0.01% 1701
2025
Q2
$539K Buy
16,921
+929
+6% +$30K ﹤0.01% 1645
2025
Q1
$474K Sell
15,992
-160
-1% -$5.51K ﹤0.01% 1756
2024
Q4
$522K Buy
16,152
+913
+6% +$32.4K ﹤0.01% 1774
2024
Q3
$578K Hold
15,239
﹤0.01% 1706
2024
Q2
$511K Buy
15,239
+5,220
+52% +$172K ﹤0.01% 1710
2024
Q1
$363K Hold
10,019
﹤0.01% 1848
2023
Q4
$330K Hold
10,019
﹤0.01% 1937
2023
Q3
$267K Buy
10,019
+449
+5% +$11K ﹤0.01% 2026
2023
Q2
$209K Hold
9,570
﹤0.01% 2253
2023
Q1
$206K Hold
9,570
﹤0.01% 2203
2022
Q4
$193K Hold
9,570
﹤0.01% 2265
2022
Q3
$230K Hold
9,570
﹤0.01% 2201
2022
Q2
$188K Buy
+9,570
New +$226K ﹤0.01% 2366

Other funds holding CDRE

MetLife Investment Management's CDRE Position: Q1 2026 in Review

MetLife Investment Management increased its Cadre Holdings (CDRE) stake by 1.4% in Q1 2026, buying an estimated $8.63K and bringing the position to 16,022 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #1758.

MetLife Investment Management first reported a position in CDRE in Q2 2022 and has held it in 16 quarters since. The position peaked at $646K in Q4 2025. 169 funds tracked by Wall St. Rank hold CDRE as of Q1 2026.

  • MetLife Investment Management held 16,022 shares of Cadre Holdings worth $492K as of Q1 2026.
  • MetLife Investment Management bought 216 Cadre Holdings shares in Q1 2026, an estimated $8.63K.
  • Cadre Holdings made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1758 holding.
  • MetLife Investment Management first reported a position in Cadre Holdings in Q2 2022 and has held it in 16 quarters since.
  • MetLife Investment Management's Cadre Holdings position peaked at $646K in Q4 2025.
  • 169 funds tracked by Wall St. Rank held Cadre Holdings as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.